Putnam Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
$3.2M Buy
102,262
+16,859
+20% +$528K ﹤0.01% 623
2023
Q3
$1.78M Buy
85,403
+4,923
+6% +$103K ﹤0.01% 746
2023
Q2
$1.93M Buy
80,480
+55,157
+218% +$1.32M ﹤0.01% 738
2023
Q1
$477K Sell
25,323
-1,067
-4% -$20.1K ﹤0.01% 949
2022
Q4
$420K Sell
26,390
-14
-0.1% -$223 ﹤0.01% 974
2022
Q3
$432K Buy
+26,404
New +$432K ﹤0.01% 966
2020
Q3
Sell
-74,844
Closed -$3.63M 823
2020
Q2
$3.63M Buy
74,844
+5,132
+7% +$249K 0.01% 521
2020
Q1
$2.95M Buy
69,712
+6,541
+10% +$276K 0.01% 533
2019
Q4
$2.7M Buy
+63,171
New +$2.7M 0.01% 687
2017
Q2
Sell
-13,178
Closed -$454K 1101
2017
Q1
$454K Sell
13,178
-3,469
-21% -$120K ﹤0.01% 1118
2016
Q4
$480K Buy
16,647
+286
+2% +$8.25K ﹤0.01% 1124
2016
Q3
$521K Sell
16,361
-21,835
-57% -$695K ﹤0.01% 1120
2016
Q2
$1.24M Sell
38,196
-41,110
-52% -$1.33M ﹤0.01% 1065
2016
Q1
$2.22M Buy
79,306
+13,548
+21% +$379K 0.01% 921
2015
Q4
$2.34M Sell
65,758
-1,523
-2% -$54.3K 0.01% 933
2015
Q3
$2.23M Buy
67,281
+2,039
+3% +$67.4K 0.01% 964
2015
Q2
$2.73M Sell
65,242
-484
-0.7% -$20.3K 0.01% 959
2015
Q1
$2.14M Sell
65,726
-2,451
-4% -$79.9K ﹤0.01% 1038
2014
Q4
$2.16M Sell
68,177
-380
-0.6% -$12.1K ﹤0.01% 1004
2014
Q3
$1.7M Buy
68,557
+1,277
+2% +$31.6K ﹤0.01% 1066
2014
Q2
$1.52M Buy
67,280
+87
+0.1% +$1.97K ﹤0.01% 1100
2014
Q1
$1.63M Sell
67,193
-98,171
-59% -$2.39M ﹤0.01% 1091
2013
Q4
$4.13M Sell
165,364
-154,929
-48% -$3.87M 0.01% 826
2013
Q3
$8.8M Sell
320,293
-36,707
-10% -$1.01M 0.02% 473
2013
Q2
$6.48M Buy
+357,000
New +$6.48M 0.02% 571